A Study of Lanadelumab in Persons With Hereditary Angioedema (HAE) Type I or II

Clinical trial NCT04130191 · COMPLETED

Trial details

NCT number: NCT04130191
Sponsor: Shire
Status: COMPLETED
Study type: OBSERVATIONAL

Hereditary Angioedema (HAE)

Start date: 2019-12-11
Primary completion: 2024-09-09
Enrollment: 140

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.